Tirzepatide ���子背景与靶点 — Deep Dive

By Editorial Desk · published 2025-08-12 · last reviewed 2025-09-29 · Guide

If you have been reading about reference standard and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2025-09-29. Where a claim depends on a specific study, the study is described rather than over-claimed.

Tirzepatide 分子背景与靶点

该化合物的名称与结构由国际非专利名称体系统一维持，不同文献中出现的同义写法主要在拼写顺序或盐形式描述上不同。研究者通常通过受体结合实验、细胞内环磷酸腺苷积累测定以及动物模型来确认其双激动活性。相当一部分分子层面的细节——例如两条受体通路之间的信号交叉作用——尚处于开放问题状态。

当前公开资料把 tirzepatide 归为肠促胰素类受体双重激动剂。它并非激素天然变体，而是经过序列改造的工程化肽。其分子量、等电点与疏水性等基础参数已在药典和化学数据库中收录，可作为分析检测和质量研究的参照。

Storage, Stability, And Analytical Verification

Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.

Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.

Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.

Tirzepatide at a glance

Analytical Characterization and Stability

Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.

Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.

Related pages on this site

• Verified reference
• Practical briefing
• Sustainable collection
• Durable briefing
• Smart report
• Tracked report
• Modular playbook
• Balanced playbook

Background And Receptor Pharmacology

Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.

Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.

Dual Incretin Receptor Pharmacology

Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.

At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.

Analytical Characterization and Storage

Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.

Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.

Reference notes

There are many bacteria of health significance found in indoor air and on indoor surfaces. The role of microbes in the indoor environment is increasingly studied using modern gene-based analysis of environmental samples. Currently, efforts are under way to link microbial ecologists and indoor air scientists to forge new methods for analysis and to better interpret the results. A large fraction of the bacteria found in indoor air and dust are shed from humans. Among the most important bacteria known to occur in indoor air are Mycobacterium tuberculosis, Staphylococcus aureus, Streptococcus pneumoniae.

Pathology Messaging Implementation Project (PMIP) is the project that introduced universal delivery of electronic pathology results to GPs in Great Britain. The resulting standard was formalised in 2003 as ISB 1557. It uses UN-EDIFACT based messages. More than 20 years later it remains extensively used by the British National Health Service (NHS) to transmit pathology orders and pathology test results. PMIP began in the United Kingdom as the PMEP (Pathology Messaging Enabling Project) under the control of the NHS Information Authority and was supported by the Royal College of Pathologists (Dr Rick Jones), the Royal College of GPs (Dr Stephen Pill) and the British Medical Association. PMIP was designed for the transmission of structured pathology orders and their associated results between pathology and primary care systems. The message definition followed the work on standardisation led by Dr Jonathan Kay and Dr John McVittie and was implemented in UN-EDIFACT as required at the time by the Department of Health. Originally messages were to be encrypted end-to-end (organisation-to-organisation) using public key infrastructure (PKI). The NHS subsequently moved to an alternative strategy using Data Transfer Service (DTS). Messages are encrypted from the pathology laboratory to the DTS server, and again from the DTS server to the General Practitioner using the PMIP interim messaging cryptographic service. The DTS provides application-to-application messaging within the NHS as well as providing a replacement for the X.400 service.

Half-Life: Counter-Strike spawned its own series which gradually became separate from the main Half-Life games, bar occasional references (such as an Easter egg referencing Portal present in Counter-Strike: Global Offensive).

Sources: en.wikipedia.org

Reference notes

=== Rifles === Lee-Enfield No. 4 – Main service rifle until the adoption of the L1A1 SLR in 1954. No. 4 Mk 2 model manufactured until 1957. A 7.62mm NATO conversion programme was attempted in the 1960s but proved abortive. De Lisle carbine - Retired in 1954 in favour of focusing on suppressed Sten variants. EM-2 rifle – Experimental rifle adopted very briefly in 1951. FN FAL – Original Belgian version adopted for troop trials as X8E1-E5, with E1 and E5 models still being in the supply chain as of January 1959. Domestically produced L1A1 Self-Loading Rifle version used as main service rifle from 1954 to 1994. Argentinian-issue FAL Paras that had been captured during the Falklands War were used by the SAS in Northern Ireland until the development of the HK G3KA4. Colt AR-15, M16 rifle - Trialled in February 1964 and adopted in April 1965. Used in tropical conditions. Also issued to special forces, Royal Marines Mountain and Arctic Warfare Cadre, and close observation platoons. Heckler & Koch G3 - Special forces issue. L85A1 rifle – Initial batches issued in 1985; frontline Army units, Royal Marines, and RAF Regiment scheduled to be fully equipped by 1987, rest of regular Army scheduled to be fully equipped by 1990. HK53 - used by Royal Military Police Close Protection Units (RMP CPU), 14 Intelligence Company, and special forces.

David Christopher Hopkinson, lately Director of Housing, Great Grimsby Borough Council. For services to Housing and to Local Government. Christiana Valerie Horrocks, lately Grade 7, Department of Health. John Anthony Howley, , lately Deputy Assistant Commissioner, Metropolitan Police. For services to the Police. Brian Joseph Hunt, Senior Professional and Technology Superintending Grade, Ministry of Defence. Frank George Henry Hunt, Grade 7, Department of Trade and Industry. Edward Graham Hutchinson. For charitable services. Jane Iris Isbister, lately Chairman, Forth Valley Health Board. For services to Health Care. Professor Kenneth Henderson Jack, Emeritus Professor, University of Newcastle-upon-Tyne, and Honorary Professor, University of Wales, Swansea. For services to Science. David Richard Jenkins, Finance Director, Sony Manufacturing Company (UK). For services to Industry in Wales. Frederick Albert Jennings, Chairman, Midlands Regional Fisheries Advisory Committee. For services to Fisheries Policy. Terence Maxfield Jobling, lately Veterinary Officer, Ministry of Agriculture, Fisheries and Food. David Lawrence Johnston, Director General, National Inspection Council for Electrical Installation Contracting. For services to Electrical Safety. David Henry Marshall Jones, lately Grade 6, the Benefits Agency, Department of Social Security. Derek Jones, lately Head, Libraries and Art Services, Richmond upon Thames. For services to Librarianship. Linda Edwina Jones, Principal Scientific Officer, the Defence Evaluation and Research Agency, Ministry of Defence.

=== Discovery === Gliotoxin was first described in 1936 by Weindling and Emerson as a metabolic product from the fungus Trichoderma lignorum. However, afterwards Weindling reported that the fungus had been misidentified based on the advice of C. Thom and M. Timonin, and that the compound instead was isolated from Gliocladium finbriatum. Contention remains on whether the fungus used by Weindling was G. finbriatum or a species of Trichoderma. The chemical structure of gliotoxin was resolved in 1958 by Bell et al. by treatment of gliotoxin on alkaline alumina. Bell and colleagues were able to determine through their structural analyses that the attachment of the disulfide bridge could not occur at any positions other than 3 and 11. This led to the elucidation that gliotoxin was an anhydropeptide related to the amino acids serine and phenylalanine. Additionally, they found that it was noteworthy that the α-carbon atoms of the cooperating α-thio-α-amino acids must have the same configuration.

Sources: en.wikipedia.org

Frequently asked questions